Older adults have low knowledge of RSV disease and vaccine eligibility
Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...
Healio1d
RSV may elevate risk for stroke, heart failure hospitalization
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
Mirage News6d
Babies Protected From RSV
The Malinauskas Labor Government is keeping South Australian babies safe from Respiratory Syncytial Virus (RSV) this winter, with a long-acting ...
GSK resolves patent lawsuit against Pfizer over RSV vaccines
British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...
McKnight's Long-Term Care News6d
Older adults more apt to receive RSV vaccine, but uptake low in long-term care: study
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
Pulmonology Advisor1d
How Do Coinfections Influence Disease Severity, Progression in Pediatric Viral LRTIs?
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
pharmaphorum2d
After GSK stumble, Pfizer moves forward with RSV vaccine
Pfizer has been awarded breakthrough status from the FDA for its respiratory syncytial virus (RSV) vaccine in pregnant women, putting the company in pole position to bring a shot to market that ...
pharmaphorum3d
MSD preparing to take on Beyfortus with RSV antibody
New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...
Business News1d
WA joins global campaign to prioritise women, babies health
This year’s World Health Day centres around improving maternal and newborn health, and kickstarts a year-long campaign from ...